Prostate Cancer | Specialty

The OncLive Prostate Cancer condition center page is a comprehensive resource for clinical news and expert insights on how to approach treatment for patients with nonmetastatic, castration-resistant, or castration-sensitive prostate cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, ongoing research, and treatment advances with androgen receptor inhibitors, PARP inhibitors, and more in prostate cancer.

Dr. Agarwal on the QoL With Apalutamide in Metastatic Castration-Sensitive Prostate Cancer

October 29th 2019

Neeraj Agarwal, MD, associate professor of medicine, University of Utah School of Medicine; and director, Genitourinary Oncology Program, Oncology Division, co-leader, Urologic Oncology Multidisciplinary Program, associate director of Clinical Trials, Huntsman Cancer Institute, University of Utah, discusses quality of life (QoL) with apalutamide (Erleada) in the treatment of patients with metastatic castration-sensitive prostate cancer.

Ongoing Study May Answer Genetic Testing Questions in Prostate Cancer

October 28th 2019

Heather H. Cheng, MD, PhD, discusses the GENTleMEN trial and the widening role of genetic testing for patients with prostate cancer.

Dr. Koo on Next-Generation Imaging in Prostate Cancer

October 25th 2019

Phillip J. Koo, MD, discusses next-generation imaging tools in prostate cancer.

Final Thoughts on Evolving Treatment of Prostate Cancer

October 25th 2019

Optimal Timing for Radium-223 With AR-Targeted Therapy

October 25th 2019

CARD: Sequencing Therapies in Metastatic Prostate Cancer

October 25th 2019

Role of Biomarkers in Metastatic Prostate Cancer

October 25th 2019

PROfound: Olaparib for HRR+ mCRPC

October 25th 2019

Triplet vs Doublet Therapy for mCSPC

October 25th 2019

Prostate Cancer: Characterize Biologies, Integrate Therapies

October 25th 2019

STAMPEDE: Docetaxel for Hormone-Naive Prostate Cancer

October 25th 2019

Clinical Phenotypes of Prostate Cancer and Prognostic Factors

October 25th 2019

Prostate Cancer: PSA-DT and Initiating AR-Targeted Therapy

October 25th 2019

QOL in Nonmetastatic Castration-Resistant Prostate Cancer

October 25th 2019

ARAMIS: Safety and Efficacy of Darolutamide in nmCRPC

October 25th 2019

Nonmetastatic Castration-Resistant Prostate Cancer

October 25th 2019

Early Salvage Radiotherapy for Early Prostate Cancer

October 25th 2019

Active Surveillance and Prognostic Value of Prostate Biopsy

October 25th 2019

Optimal ADT for Patients With Prostate Cancer and CV History

October 25th 2019

Combination Therapy for Localized Prostate Cancer

October 25th 2019